News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
255,168 Results
Type
Article (5973)
Company Profile (29)
Press Release (249166)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (87837)
Career Advice (473)
Deals (16512)
Drug Delivery (11)
Drug Development (21333)
Employer Resources (32)
FDA (4074)
Job Trends (4568)
News (130072)
Policy (8444)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (348)
Accelerated approval (11)
Adcomms (4)
Allergies (21)
Alliances (16302)
ALS (54)
Alzheimer's disease (401)
Antibody-drug conjugate (ADC) (71)
Approvals (4219)
Artificial intelligence (133)
Autoimmune disease (59)
Automation (9)
Bankruptcy (107)
Best Places to Work (3392)
Biosimilars (36)
Biotechnology (30)
Bladder cancer (46)
Brain cancer (14)
Breast cancer (159)
Cancer (1195)
Cardiovascular disease (85)
Career advice (406)
Career pathing (4)
CAR-T (74)
CDC (4)
Cell therapy (192)
Cervical cancer (7)
Clinical research (18806)
Collaboration (479)
Compensation (432)
Complete response letters (12)
COVID-19 (464)
CRISPR (14)
C-suite (447)
Cystic fibrosis (32)
Data (1764)
Denatured (2)
Depression (29)
Dermatology (18)
Diabetes (99)
Diagnostics (2397)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (60)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (47)
Earnings (45410)
Editorial (6)
Employer branding (6)
Employer resources (34)
Events (42456)
Executive appointments (489)
FDA (4965)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (447)
Gene editing (27)
Generative AI (7)
Gene therapy (115)
GLP-1 (172)
Government (534)
Guidances (207)
Healthcare (5610)
HIV (12)
Huntington's disease (6)
IgA nephropathy (22)
Immunology and inflammation (47)
Immuno-oncology (14)
Indications (30)
Infectious disease (507)
Inflammatory bowel disease (37)
Inflation Reduction Act (3)
Influenza (10)
Intellectual property (40)
Interviews (57)
IPO (8478)
IRA (3)
Job creations (1264)
Job search strategy (367)
JPM (4)
Kidney cancer (12)
Labor market (11)
Layoffs (116)
Leadership (6)
Legal (2685)
Liver cancer (23)
Longevity (5)
Lung cancer (132)
Lymphoma (83)
Machine learning (9)
Management (11)
Manufacturing (196)
MASH (55)
Medical device (4391)
Medtech (4410)
Mergers & acquisitions (8531)
Metabolic disorders (266)
mRNA (12)
Multiple sclerosis (24)
NASH (6)
Neurodegenerative disease (78)
Neuropsychiatric disorders (15)
Neuroscience (729)
NextGen: Class of 2026 (1794)
Non-profit (800)
Now hiring (7)
Obesity (107)
Opinion (35)
Ovarian cancer (35)
Pain (39)
Pancreatic cancer (63)
Parkinson's disease (69)
Partnered (12)
Patents (76)
Patient recruitment (132)
Peanut (6)
People (27396)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5577)
Phase 2 (8284)
Phase 3 (6503)
Pipeline (2793)
Policy (21)
Postmarket research (662)
Preclinical (2199)
Press Release (67)
Prostate cancer (69)
Psychedelics (5)
Radiopharmaceuticals (139)
Rare diseases (226)
Real estate (2029)
Recruiting (9)
Regulatory (6247)
Reports (18)
Research institute (362)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (4)
RSV (2)
Schizophrenia (66)
Series A (66)
Series B (64)
Service/supplier (2)
Sickle cell disease (15)
Special edition (1)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1135)
State (1)
Stomach cancer (1)
Supply chain (21)
Tariffs (7)
The Weekly (1)
Vaccines (124)
Venture capital (13)
Weight loss (37)
Women's health (10)
Worklife (1)
Date
Today (45)
Last 7 days (185)
Last 30 days (843)
Last 365 days (9945)
2026 (2960)
2025 (10098)
2024 (12224)
2023 (14533)
2022 (20457)
2021 (21868)
2020 (19720)
2019 (14316)
2018 (11015)
2017 (10883)
2016 (10015)
2015 (13180)
2014 (10375)
2013 (8370)
2012 (9066)
2011 (9474)
2010 (9291)
Location
Africa (203)
Alabama (20)
Alaska (2)
Arizona (88)
Arkansas (2)
Asia (12629)
Australia (1782)
California (4101)
Canada (1922)
China (207)
Colorado (173)
Connecticut (196)
Delaware (82)
Europe (27404)
Florida (644)
Georgia (92)
Idaho (24)
Illinois (196)
India (29)
Indiana (164)
Iowa (9)
Japan (210)
Kansas (40)
Kentucky (21)
Louisiana (11)
Maine (55)
Maryland (389)
Massachusetts (3275)
Michigan (150)
Minnesota (250)
Mississippi (1)
Missouri (38)
Montana (18)
Nebraska (14)
Nevada (59)
New Hampshire (27)
New Jersey (1376)
New Mexico (8)
New York (1036)
North Carolina (570)
North Dakota (4)
Northern California (2161)
Ohio (132)
Oklahoma (9)
Oregon (7)
Pennsylvania (778)
Puerto Rico (4)
Rhode Island (24)
South America (315)
South Carolina (20)
Southern California (1527)
Tennessee (80)
Texas (650)
United States (14940)
Utah (130)
Vermont (1)
Virginia (95)
Washington D.C. (17)
Washington State (353)
West Virginia (2)
Wisconsin (81)
Wyoming (2)
255,168 Results for "angion biomedica corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Elicio Therapeutics Announces Completion of Merger with Angion Biomedica
Elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced the closing of its previously announced merger with Angion Biomedica Corp.
June 1, 2023
·
8 min read
Business
Elicio Therapeutics Enters Into Merger Agreement with Angion Biomedica
Elicio Therapeutics entered into a merger agreement as a wholly-owned subsidiary of Angion Biomedica Co. on Tuesday, becoming a Nasdaq-listed company.
January 17, 2023
·
1 min read
·
Hayley Shasteen
Press Releases
Resverlogix Corp. Announces Issuance of MCTO by ASC
April 2, 2026
·
4 min read
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
·
2 min read
Press Releases
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia
October 9, 2025
·
5 min read
Press Releases
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
April 17, 2026
·
1 min read
Press Releases
Resverlogix Corp. Provides Bi-Weekly MCTO Status Update
April 1, 2026
·
4 min read
Press Releases
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
March 5, 2026
·
3 min read
Press Releases
NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study
April 7, 2026
·
1 min read
Press Releases
Science Corp. Appoints Murat Günel, MD, as Medical Director for Brain-Computer Interfaces
March 31, 2026
·
3 min read
1 of 25,517
Next
